← Evidence map

TrialTopics in spinal cord injury rehabilitation2025

Immunomodulation for Primary Prevention of Urinary Tract Infections in Patients With Spinal Cord Injury or Disease During Primary In-House Rehabilitation: Results From a Randomized Placebo-Controlled Feasibility Trial (UroVaxom-Pilot).

Jörg Krebs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Immunomodulation for Primary Prevention of Urinary Tract Infections in Patients With Spinal Cord Injury or Disease During Primary In-House Rehabilitation: Results From a Randomized Placebo-Controlled Feasibility Trial (UroVaxom-Pilot). | OpenQuestion